Drug intelligence / Profile preview

collagenase type 1A

Development stage
Unknown
Modality
Therapeutic Enzymes → Recombinant Proteins and Enzymes
Administration
Topical (for Wound Debridement In Experimental/clinical Use), Intralesional (for Experimental And Select Human Therapeutic Uses), In Vitro/ex Vivo Tissue Application
01

Overview

Collagenase type 1A is a proteolytic enzyme preparation derived from the bacterium Clostridium histolyticum, characterized by its ability to break down peptide bonds in native collagen fibers, especially types I, II, and III collagens. It is used primarily in biomedical research and tissue dissociation procedures for isolating cells from animal tissues, and it also has emerging use in treating fibrotic disorders such as Peyronie's disease, Dupuytren's contracture, keloids, and intervertebral disc herniation. The mechanism of action involves enzymatic cleavage of the triple helical region of collagen, leading to local degradation and lysis of collagenous extracellular matrices[1][2][5].

Other names
collagenase type IAcollagenase type Ibacterial collagenase type 1A
02

Targets

COL1 (Collagen type I)

Beyond the preview

Go deeper on collagenase type 1A.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Clinical trials

Full profile access

Follow clinical development from study design and recruitment through results.

  • Trial phase
  • Status
  • Readouts

Indications & development

Full profile access

Explore development by indication, patient population, and geography.

  • Indications
  • Development status
  • Countries

Licensing & deals

Full profile access

Trace asset ownership, licensing agreements, and commercial partnerships.

  • Partners
  • Deal terms
  • Milestones

Patents & exclusivity

Full profile access

Explore the patent landscape and regulatory exclusivity around an asset.

  • Patents
  • Expiration dates
  • Exclusivity

Competitive landscape

Full profile access

Compare development programs by target, modality, and indication.

  • Competing assets
  • Targets
  • Development stage

Research & analysis

Full profile access

Connect source evidence and development news to your research questions.

  • Publications
  • News
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on collagenase type 1A.

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call